QUALITY ASSURANCE IN THE PHARMACEUTICAL INDUSTRY

Giulia AURIEMMA QUALITY ASSURANCE IN THE PHARMACEUTICAL INDUSTRY

0760200031
DIPARTIMENTO DI FARMACIA
EQF7
PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY
2020/2021

YEAR OF DIDACTIC SYSTEM 2016
SECONDO SEMESTRE
CFUHOURSACTIVITY
540LESSONS
Objectives
COURSE OBJECTIVES AND LEARNING OUTCOMES

THE COURSE AIMS AT ACQUIRING KNOWLEDGE ON QUALITY ASSURANCE (QA) IN PHARMACEUTICAL COMPANIES AND THE RELATED REGULATORY STANDARDS AND TO DEVELOP SKILLS ON QUALITY, SAFETY AND EFFICACY OF PHARMACEUTICAL PRODUCTS. TOOLS SUCH AS CONTROL AND DOCUMENTATION MANAGEMENT WILL BE ACQUIRED. AT THE END OF THE COURSE THE STUDENT WILL BE ABLE TO DESCRIBE QA PROCESSES OF A PHARMACEUTICAL COMPANY AND TO ANALYZE A QUALITY SYSTEM (CASE-STUDY).
Prerequisites
PREREQUISITES

NONE. HIGHLY RECOMMENDED BASIC KNOWLEDGE OF:
- PREPARATION AND CONTROL OF PHARMACEUTICAL PRODUCTS
- PREMISES AND EQUIPMENT OF OF A PHARMACEUTICAL INDUSTRY
- "UNITARY" OPERATIONS FOR THE PREPARATION OF MEDICINAL PRODUCTS
Contents
COURSE CONTENTS

1. INTRODUCTION
QUALITY CONCEPTS IN THE PHARMACEUTICAL INDUSTRY
INTRODUCTION ON R&D (DISCOVERY, DEVELOPMENT AND MARKETING) AND QUALITY SYSTEM (QS) IN THE PHARMACEUTICAL INDUSTRY
ORGANIZATION, PERSONNEL AND KEY ROLES (PRODUCTION – QUALITY CONTROL - QUALITY ASSURANCE – PHARMACOVIGILANCE – REGULATORY AFFAIRS)

2. REGULATORY PARADIGMS OF GOVERNANCE AND REGULATION OF QUALITY
LEGISLATION, REGULATORY GUIDANCE AND RELATED DOCUMENTS
REGULATORY AUTHORITIES (AIFA, EMA, FDA, ETC.)
GOOD MANUFACTURING PRACTICES (GMP)
PRODUCTION AUTHORIZATION (PA) AND MARKETING AUTHORIZATION (AIC) OF A MEDICINAL PRODUCT (LEGISLATIVE PROCEDURES)
NEW QUALITY PARADIGMS: ICH Q-8 (QUALITY BY DESIGN), ICH Q-9 (QUALITY RISK MANAGEMENT) AND ICH Q-10 (PHARMACEUTICAL QUALITY SYSTEMS).

3. PHARMACEUTICAL QUALITY MANAGEMENT SYSTEM
GOOD MANUFACTURING PRACTICES (GMPS) - EUDRALEX VOLUME 4

PHARMACEUTICAL QUALITY SYSTEM
PERSONNEL AND ORGANIZATION. PERSONNEL QUALIFICATION. TRAINING. “QUALIFIED PERSON” ETC.
PREMISE AND EQUIPMENT
DOCUMENTATION. GENERATION AND CONTROL OF DOCUMENTATION. STANDARD OPERATIVE PROCEDURES (SOP). MASTER BATCH RECORD. SITE MASTER FILE (SMF), ETC.
PRODUCTION AND QUALITY CONTROL. PREVENTION OF CROSS-CONTAMINATION IN PRODUCTION; VALIDATION; PROCESSING OPERATIONS: INTERMEDIATE AND BULK PRODUCTS; PACKAGING MATERIALS; FINISHED PRODUCTS.
INSPECTIONS
OOT (OUT-OF-TREND) EVALUATION; OOS (OUT OF SPECIFICATION) AND DEVIATIONS
MANUFACTURE OF STERILE MEDICINAL PRODUCTS

4. ISO

5. EUDRALEX VOLUME 4_ ANNEXES

6. SEMINARS WITH EXPERTS FROM SEVERAL PHARMACEUTICAL INDUSTRIES
Teaching Methods
METHODS AND DIDACTIC STRATEGIES

LECTURES, SEMINARS, GROUPS OF STUDY OR WORK, PROJECT WORK, INTERACTION WITH THE TEACHER AND WITH EXPERTS OF THIS SECTOR.
Verification of learning
VERIFICATION OF STUDENTS' RESULTS

THE ACHIEVEMENT OF THESE OBJECTIVES WILL BE VERIFIED BY BOTH A WRITTEN AND AN ORAL EXAM; THE EVALUATION WILL BE EXPRESSED IN THIRTIETHS. IN ORDER TO TAKE THE ORAL EXAM, IT IS NECESSARY TO PASS THE WRITTEN EXAM (MINIMUM MARK 18/30).
THE WRITTEN TEST WILL BE CARRIED OUT AT THE END OF THE COURSE; IT IS AIMED AT EVALUATING KNOWLEDGE AND SKILLS; IT WILL BE ARTICULATED INTO APPROXIMATELY 20 QUESTIONS (MAXIMUM DURATION: 90 MINUTES).
THE ORAL EXAM IS AIMED AT EVALUATING THE THEORETICAL KNOWLEDGE, THE AUTONOMY OF ANALYSIS, THE ABILITY TO REWORK CONTENTS INTO THE CORRECT FORMAT FOR PROFESSIONAL USE.
THE FINAL EVALUATION IS OBTAINED AS THE MEDIUM OF EACH PARTIAL MARKS.
THE MINIMUM MARKS (18/30) IS ATTRIBUTED TO STUDENTS WITH A FRAGMENTARY KNOWLEDGE AND A LIMITED CAPACITY TO REWORK THE TREATED CONCEPTS.
THE MAXIMUM MARKS (30/30) IS ATTRIBUTED TO STUDENTS ABLE TO DEMONSTRATE A COMPLETE KNOWLEDGE OF THE METHODOLOGIES AND A NOTABLE ABILITY TO REWORK CONTENTS.
THE PRIDE WILL BE ATTRIBUTED ONLY TO STUDENTS WITH A SIGNIFICANT MASTERY OF THE METHODOLOGIES, WITH A HIGH ABILITY TO REWORK THE ACQUIRED KNOWLEDGE.
Texts
RECOMMENDED BOOKS

EU LEGISLATION – EUDRALEX (LINK HTTP://EC.EUROPA.EU/HEALTH/DOCUMENTS/EUDRALEX/INDEX_EN.HTM)
PRINCIPI DI TECNOLOGIA FARMACEUTICA. PAOLO COLOMBO, FRANCO ALHAIQUE, CARLA CARAMELLA, BICE CONTI, ANDREA GAZZANIGA, ELENA VIDALE - SECONDA EDIZIONE. CASA EDITRICE AMBROSIANA. ZANICHELLI
LEGISLAZIONE FARMACEUTICA DI: PAOLA MINGHETTI, MARCELLO MARCHETTI EDITORE: CEA EDIZIONE: 8
More Information
//
  BETA VERSION Data source ESSE3 [Ultima Sincronizzazione: 2022-05-23]